Roca Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 6

Roca Therapeutics General Information

Description

Developer of a biotechnology platform designed to create cancer therapies to give new life and vision to patients. The company's platform focuses on developing new anti-cancer therapeutic strategies, in particular by targeting several major players in tumor development and aggressiveness, inflammation, chronic immunosuppression, and tumor cell proliferation, enabling patients to receive a new chance at life through the treatment of rare cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Institut Delvalle
  • 27 Rue Du Professeur Delvalle
  • 06000 Nice
  • France
+33 06
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Institut Delvalle
  • 27 Rue Du Professeur Delvalle
  • 06000 Nice
  • France
+33 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roca Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A) 07-Apr-2023 Completed Generating Revenue
5. Seed Round 10-May-2022 Completed Generating Revenue
4. Grant Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 28-Apr-2021 Completed Startup
To view Roca Therapeutics’s complete valuation and funding history, request access »

Roca Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
To view Roca Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Roca Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Roca Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
3B Future Health Fund Venture Capital Minority
SATT Sud-Est Corporation Minority
Université Côte d'Azur University
Bpifrance Sovereign Wealth Fund
Incubator Provence Côte d'Azur Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Roca Therapeutics FAQs

  • When was Roca Therapeutics founded?

    Roca Therapeutics was founded in 2021.

  • Where is Roca Therapeutics headquartered?

    Roca Therapeutics is headquartered in Nice, France.

  • What is the size of Roca Therapeutics?

    Roca Therapeutics has 8 total employees.

  • What industry is Roca Therapeutics in?

    Roca Therapeutics’s primary industry is Drug Discovery.

  • Is Roca Therapeutics a private or public company?

    Roca Therapeutics is a Private company.

  • What is Roca Therapeutics’s current revenue?

    The current revenue for Roca Therapeutics is .

  • How much funding has Roca Therapeutics raised over time?

    Roca Therapeutics has raised $1.78M.

  • Who are Roca Therapeutics’s investors?

    3B Future Health Fund, SATT Sud-Est, Université Côte d'Azur, Bpifrance, and Incubator Provence Côte d'Azur are 5 of 6 investors who have invested in Roca Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process